GE11 Peptide Conjugated Selenium Nanoparticles for EGFR Targeted Oridonin Delivery to Achieve Enhanced Anticancer Efficacy by Inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/Mek/Erk Pathways
Drug Delivery - United Kingdom
doi 10.1080/10717544.2017.1386729
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Informa UK Limited